The previous studies reported that increased expression of PD-1 and PD-L1 was associated with more aggressive PCa [44, 45], which was in line with our findings that patients in the high-risk group were more likely to develop BCR and were associated with high-grade and advanced-stage PCa. This evidence concerns the gene BCR and posterior cortical atrophy.